Detalhe da pesquisa
1.
A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
J Virol
; 96(18): e0133722, 2022 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36069551
2.
Protocol to evaluate the inflammatory response in human macrophages induced by SARS-CoV-2 spike-pseudotyped VLPs.
STAR Protoc
; 4(1): 102083, 2023 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36853685
3.
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection.
Vaccines (Basel)
; 11(3)2023 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36992129
4.
Oral Immunization with rVSV Bivalent Vaccine Elicits Protective Immune Responses, Including ADCC, against Both SARS-CoV-2 and Influenza A Viruses.
Vaccines (Basel)
; 11(9)2023 Aug 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37766083